Does UPADACITINIB Cause Contraindicated product administered? 35 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Contraindicated product administered have been filed in association with UPADACITINIB (Rinvoq). This represents 0.1% of all adverse event reports for UPADACITINIB.
35
Reports of Contraindicated product administered with UPADACITINIB
0.1%
of all UPADACITINIB reports
19
Deaths
23
Hospitalizations
How Dangerous Is Contraindicated product administered From UPADACITINIB?
Of the 35 reports, 19 (54.3%) resulted in death, 23 (65.7%) required hospitalization, and 24 (68.6%) were considered life-threatening.
Is Contraindicated product administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Contraindicated product administered?
ABATACEPT (13,559)
METHOTREXATE (13,121)
ETANERCEPT (12,062)
TOCILIZUMAB (11,547)
ADALIMUMAB (11,270)
LEFLUNOMIDE (11,206)
HYDROXYCHLOROQUINE (10,557)
RITUXIMAB (10,479)
INFLIXIMAB (9,618)
SULFASALAZINE (8,698)
Which UPADACITINIB Alternatives Have Lower Contraindicated product administered Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL